Unicycive Therapeutics Inc Asset Resilience Ratio

Latest as of June 2026: 23.93%

Unicycive Therapeutics Inc asset resilience ratio. Unicycive Therapeutics Inc (UNCY) has an Asset Resilience Ratio of 23.93% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See UNCY cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$17.24 Million

Cash + Short-term Investments

Total Assets

$72.03 Million

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio of Unicycive Therapeutics Inc (2024–2025)

Asset resilience ratio of Unicycive Therapeutics Inc from 2024 to 2025. This chart shows how Unicycive Therapeutics Inc's Asset Resilience Ratio has changed over time. Read Unicycive Therapeutics Inc debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Unicycive Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Unicycive Therapeutics Inc asset portfolio.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$17.24 Million	23.93%
Total Liquid Assets	$17.24 Million	23.93%

Asset Resilience Insights

Good Liquidity Position: Unicycive Therapeutics Inc maintains a healthy 23.93% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Unicycive Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare Unicycive Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Unicycive Therapeutics Inc Asset Resilience Ratio by Year (2024–2025)

Unicycive Therapeutics Inc asset resilience ratio by year from 2024 to 2025. The table below shows the annual Asset Resilience Ratio data for Unicycive Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	24.57%	$12.07 Million	$49.13 Million	--
2024-12-31	0.00%	$0.00	$31.67 Million	--

pp = percentage points

About Unicycive Therapeutics Inc

NASDAQ:UNCY USA Biotechnology

Market Cap

$98.34 Million

Market Cap Rank

#19061 Global

#4405 in USA

Share Price

$3.59

Change (1 day)

+2.87%

52-Week Range

$3.36 - $8.56

All Time High

$8.56